Ping An Healthcare and Technology Co Ltd
HKEX:1833
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.32
18.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Ping An Healthcare and Technology Co Ltd
Ping An Healthcare and Technology Co Ltd
Cash & Cash Equivalents
Ping An Healthcare and Technology Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ping An Healthcare and Technology Co Ltd
HKEX:1833
|
Cash & Cash Equivalents
¥3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Cash & Cash Equivalents
¥183B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
8%
|
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Cash & Cash Equivalents
¥65.3B
|
CAGR 3-Years
80%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
JD Health International Inc
HKEX:6618
|
Cash & Cash Equivalents
¥18.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
310%
|
CAGR 10-Years
N/A
|
|
|
Meituan
HKEX:3690
|
Cash & Cash Equivalents
¥54.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
JD.Com Inc
HKEX:9618
|
Cash & Cash Equivalents
¥99.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
Ping An Healthcare and Technology Co Ltd
Glance View
Ping An Healthcare & Technology Co. Ltd. is an investment holding company, which engages in the provision of online medical and wellness services. The company is headquartered in Shanghai, Shanghai and currently employs 3,425 full-time employees. The company went IPO on 2018-05-04. The firm operates four segments. The Health Mall segment provides Chinese and western medicines (over-the-counter medicines), nutritional healthcare, medical equipment and other products. The Consumer Healthcare is involved in providing individual and corporate clients with a range of health services, including physical examination, medical beauty, oral and genetic testing. The Online Medical Services segment provides users with online consultation, referral, registration, online medication purchase and drug delivery services. The services are provided through its products which are Health 360 and Private Doctor Membership. The Health Management and Wellness Interaction segment provides advertising products and services for corporate clients.
See Also
What is Ping An Healthcare and Technology Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3B
CNY
Based on the financial report for Jun 30, 2024, Ping An Healthcare and Technology Co Ltd's Cash & Cash Equivalents amounts to 3B CNY.
What is Ping An Healthcare and Technology Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-12%
Over the last year, the Cash & Cash Equivalents growth was -35%. The average annual Cash & Cash Equivalents growth rates for Ping An Healthcare and Technology Co Ltd have been -7% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
